Receive our newsletter – data, insights and analysis delivered to you
  1. News
November 12, 2014

Zyga enrols first patient in DUET trial of Glyder facet restoration device

US-based medical device firm Zyga Technology has enrolled the first patient in DUET, a multi-site trial of the GlyDer Facet restoration device in patients with lumbar facet pain syndrome.

US-based medical device firm Zyga Technology has enrolled the first patient in DUET, a multi-site trial of the Glyder facet restoration device in patients with lumbar facet pain syndrome.

The US multicentre single-arm trial will be conducted at five sites and includes 20 patients.

Zyga is focused on the design, development and commercialisation of minimally invasive products to treat underserved conditions of the lumbar spine.

Greater Baltimore Medical Center Neurosurgery chief Reginald Davis said: "The Glyder device fills a significant gap in the care continuum for facet joint pain.

"The Glyder device is designed to provide long-term relief of facet joint pain through a non-fusion procedure that preserves surrounding anatomy and future treatment options."

"When conservative treatments such as facet injection or rhizotomy fail to provide relief for these patients, our only recourse has been to perform a fusion, a procedure that eliminates motion and permanently alters the natural movement of the spine.

"The Glyder device is designed to provide long-term relief of facet joint pain through a non-fusion procedure that preserves surrounding anatomy and future treatment options."

Content from our partners
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment

Low back pain (LBP) is listed as the second most common cause of disability in US adults, by the Centers for Disease Control and Prevention.

According to reports, more than 30% of all chronic low back pain derives from the facet joint, with an estimated 3.2 million facet joint interventions performed annually.

Zyga president Jim Bullock said: "It is rare and exciting to develop a truly novel technology that fills such a clear unmet clinical need.

"With the DUET clinical study, as well as a 150-patient Post Market Registry in the EU to be launched later this year, we continue to build the clinical evidence needed to support market adoption of the Glyder facet restoration device."

Zyga’s Glyder facet restoration device is intended to provide relief from lumbar facet pain, restoring facet joint function, while preserving native anatomy.

It consists of two small polymer discs that cover the articulating surfaces of the facet joint.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU